A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis

Summary

The objectives of this study are to assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of SB414 in subjects with mild to moderate plaque psoriasis.

Timeline

Start

2017-10-13

Primary completion

2018-01-31

Completion

2018-02-06

Drugs

Indications